glp-1 drugs and depression The risk of depression, anxiety, suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy Ozempic and the Mind: Personality
Description
GLP-1RAs and heart failure The prevalence of left ventricular ejection fraction (LVEF)-preserved heart failure continues to increase

Additionally, we manually searched the websites of the European Association for the Study of Diabetes and American Diabetes Association scientific meetings, as well as ClinicalTrials.gov, to retrieve additional qualified trials or search the database for any additional information on trials that have been identified

It is injected once weekly at doses ranging from 0.25 mg (starting dose) to 2.0 mg (maximum dose for diabetes)
Obesity surgery vol

poison centers involving a GLP-1 RA

References Istituto Superiore di Sanit (2021) Dati Sorveglianza PASSI 20202021
